Smoking Ban in Austria Passed After Years of Political Wrangling

Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC

Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies

Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy

Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data

Key Findings from the CAR T-Cell Study Presented at the 2019 AACR Annual Meeting

Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?

Antibody–Drug Conjugates in NSCLC: Complexities, Challenges, and Potential

Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel

Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski

Making Headway with Lorlatinib

Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We Ready for a ‘Blood-First’ Approach?